By: Joseph Mullings of The Mullings Group A great recruiter is a combination of many things. A great networker, empathetic, a student of the technology they specialize in, a deal maker and most of all we are excellent at facilitating … More… →
By: Joe Mullings Read a headline yesterday on the Heartware LVAD device in one of the industry’s leading rags. “Heartware LVA device led to patient death says the FDA”. First, my condolences go out to the family and friends who … More… →
In August 2012 a Hematology client approach our firm, The Mullings Group, with a challenging search that would be responsible for their territory expansion into Russia, Kazakhstan, and the CIS countries. Our client was in need of a Scientific Affairs … More… →
By: Joe Mullings The first month and a half of 2013 has been a fantastic start to the year for our firm. This is good news. As I say, we are an early leading indicator of what is likely to … More… →
Sharing syringes is a big no-no. But despite the warnings, needle sharing among injection drug users is still a significant cause for the spread of HIV and other infectious diseases. But HIV transmission due to needle sharing could be nearly eradicated by merely changing the design of … More… →
input[type="submit"] {display:inherit;}